Celgene And Mesoblast Enter Into Equity Placement and Right

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Celgene And Mesoblast Enter Into Equity Placement and Right of First Refusal Agreement To Certain Disease Fields

MELBOURNE, Australia and NEW YORK, April 12, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that the Company has entered into an Agreement with US-based Celgene Corporation, a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Pursuant to this Agreement, Celgene will purchase Mesoblast stock and has a six-month right of first refusal to certain disease fields.

Under the terms of the Agreement, Celgene will purchase 15.3 million ordinary shares in Mesoblast Limited for a consideration of A$58.5 million/US$45 million at a price of A$3.82 per share. In addition, Celgene has a six-month right of first refusal with respect to Mesoblast's proprietary mesenchymal lineage adult stem cell product candidates for the prevention and treatment of acute graft versus host disease (GVHD), certain oncologic diseases, inflammatory bowel diseases, and organ transplant rejection.

Mesoblast's Chief Executive, Silviu Itescu, said: "We are pleased that Celgene, as a global leader in development and commercialization of innovative therapies for oncologic and immune-mediated diseases, has chosen to make this investment in Mesoblast. We look forward to working closely together and building a strong and fruitful relationship."

Celgene's President & COO, Mark Alles, said: "Today's agreement provides an opportunity for Celgene to add to its leading cellular and regenerative medicine pipeline. We are committed to developing important new therapies for significant medical diseases that are currently not being adequately addressed."

Mesoblast Limited

Mesoblast Limited (ASX: MSB; USOTC: MBLTY) is a global leader in regenerative medicine. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late stage product candidates. Mesoblast's allogeneic or 'off-the-shelf' cell product candidates target significantly advanced stages of diseases where there are highly unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic/inflammatory disorders and oncology/hematology conditions. The lead therapeutic product candidates under investigation include MPC-150-IM for chronic congestive heart failure, in partnership with Teva Pharmaceutical Industries Ltd., MPC-06-ID for chronic discogenic low back pain, MSC-100-IV for acute GVHD, and MPC-300-IV for biologic refractory rheumatoid arthritis and diabetic nephropathy.

Julie Meldrum Global Head of Corporate Communications Mesoblast Limited T: +61 (0) 3 9639 6036 E: julie.meldrum@mesoblast.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Millrose Faces Class Action: Misleading Investors Allege

Updated Category News Views 79

The Tides Turn Against Millrose The market's got a short memory, but when a stock like Millrose Properties, Inc. (NYSE: MRP) hits a snag, folks tend to sit up and take notice. And snag it hit, falling from grace faster than a lead balloon. What we're looking at here is a messy affair of allegedly misleading claims and an 8.5% drop in share price that left quite a few...

Continue Reading
Coastal Financial Faces Crisis as Lawsuit Deadline Looms

Updated Category News Views 50

Coastal Financial Caught in a Storm Folks are buzzing about the drama unraveling around Coastal Financial (NASDAQ:CCB), and it's not for good reasons. Shares nose-dived a jaw-dropping 43.52%, leaving investors feeling like they got hit by a freight train. The culprit? A messy soup of financial woes and alleged misinformation. A Deep Dive into the Numbers Let's rip the...

Continue Reading
Florida Parents Push for National Online Safety Deal

Updated Category News Views 62

Florida's Call for Safeguarding Kids Online You know, it's not every day you see a political agreement that can unite parents regardless of which side of the fence they're on, but this one seems to be doing the trick. The call for better online safety measures for kids in Florida is gaining serious muscle, with two-thirds of parents backing the state's participation in a...

Continue Reading
Inventive Golf Accessory Offers Fun with Sound Effects

Updated Category News Views 60

Who Knew Golf Clubs Could Sound This Fun? When you think of golf, what comes to mind? Calm fairways, a perfect swing, perhaps the pop of a cork at the clubhouse. But what's this? An accessory promising to shake things up with a bit of character and a splash of sound effects? BUNKER BUDDIES Change the Game There's an inventor out in Highland Heights, Ohio, who’s stirred...

Continue Reading
Anchorage Home Sellers: Pricing Strategy Insights Revealed

Updated Category News Views 86

Understanding Anchorage's Real Estate Climate In the bustling world of Anchorage real estate, it's not what you hear nationally that counts—it's about reading the nuances of your own backyard. That’s the principal mantra disseminated by Real Estate Expert Gary Cox, affectionately known as the 'King', in his latest discourse with HelloNation. A pertinent perspective...

Continue Reading
CREB Unlocks 8.50% APY Bonds for IRA Investors

Updated Category News Views 108

CRET Broadens the Path to Fixed-Income Security If you're the type who gets a rash just thinking about stock market jitters, pay attention: Compound Real Estate Bonds (CREB) has cracked the door open a bit wider for your retirement peace of mind. They've teamed up with Equity Trust to offer their rock-solid 8.50% APY bonds through self-directed IRAs. That's right—these...

Continue Reading
Munters Boosts Production Capabilities with New Investments

Updated Category News Views 74

Making Moves in the Data Center Supply Chain I tell you, Munters ain't holding back—they're diving headfirst into beefing up their data center supply chain. This Swedish company is shaking hands with Lordan to churn out coils right in the heart of Texas. And they're not stopping there. They’re doubling down across the pond by expanding their Italian facility dedicated...

Continue Reading
Asphalt Additives Market Set for $7.07B Boom by 2031

Updated Category News Views 65

Asphalt Additives: A Lucrative Growth Path Let me tell you, the asphalt additives market isn't just sticking to the roads; it's rolling out real potential. Heading for a $7.07B finish line by 2031 with a steady pace of 7.3% CAGR, it's a road worth staking your claims on. The underlying story? It's more than just laying tar. Pavement to Profit: Key Drivers The asphalt...

Continue Reading
SwitchBot Unveils Curtain Track 4: Less Hassle, More Smarts

Updated Category News Views 84

SwitchBot's Ambitious Leap in Curtain Automation Well, it seems like SwitchBot is shaking things up in the world of home automation. They’re rolling out the Curtain Track 4, and it’s packed with enhancements that aim to make your drapery as lazy as you are. Imagine getting up close without any fuss—just a neat 30-second setup on those U-rail curtains and we’re off...

Continue Reading
Valens Semiconductor Shows Strong Q3 2026 Performance

Updated Category News Views 74

Valens Semiconductor Surpasses Revenue Expectations Here's the scoop: Valens Semiconductor (NYSE: VLN) just blew past their Q3 2026 revenue guidance with a solid $21.9 million, marking a high point in CEO Yoram Salinger's first year at the helm. Sure, they booked a net loss of $5.5 million, but let's face it, these results show a healthy trajectory, especially if you look...

Continue Reading

Top 5 Most Recently Viewed Articles

Kroger Health Advances Drug Safety Education for Youth

Updated Category News Views 103

Kroger Health Advances Drug Safety Education for Youth Kroger Health, the healthcare segment of The Kroger Co. (NYSE: KR), recently celebrated a significant achievement by supporting over 250,000 students in completing its innovative drug safety program, Prescription Drug Safety: Know the Truth. This initiative is part of Kroger Health's steadfast commitment to promoting...

Continue Reading
Milan Stock Market Summary: Key Performers and Trends

Updated Category News Views 483

Overview of Milan Stock Market Performance The Milan Stock Exchange closed on a slightly lower note, indicating mixed sentiments among investors. While some sectors showed resilience, the overall trend reflected a cautious approach as stocks fluctuated consistently during the trading session. Key Performers in the Market Among the noteworthy performers of the day, Iveco...

Continue Reading
Baidu's Growing Options Activity: A Comprehensive Review

Updated Category News Views 129

Baidu's Growing Options Activity: A Comprehensive Review Recently, market analysts have witnessed a notable surge in options trading for Baidu, showing significant bullish sentiment from investors. This article delves into the various aspects behind the rising options activity for Baidu (NASDAQ: BIDU), providing a clear picture of the trends and movements affecting this...

Continue Reading
FiveTwenty and STACKIT Become Silver Members of Cloud Foundry

Updated Category News Views 153

FiveTwenty and STACKIT Join Cloud Foundry Foundation Cloud Foundry Foundation, a premier open-source platform dedicated to cloud applications, welcomes its latest Silver Members, FiveTwenty and STACKIT. This addition enriches a community that promotes collaboration and innovation across various sectors through cloud-native applications. Strengthening the Community Since...

Continue Reading
Experience Effortless Cryptocurrency Mining with ALL4 Mining

Updated Category News Views 127

Revolutionize Your Crypto Mining Experience ALL4 Mining is transforming the way individuals engage with cryptocurrency mining through its innovative mobile application. By leveraging this robust platform, users can mine Bitcoin, Dogecoin, Litecoin, and many more without the traditional hurdles associated with hardware setups. Forget about the hefty machinery, expensive...

Continue Reading